This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products and medical supplies. The contract, valued at $7,629.33, covers the procurement of TNKASE 50 MG KITS and has an ultimate completion date of June 27, 2022.
Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. Additionally, Cencora, Inc. holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
The contract award did not have a set-aside designation, indicating full and open competition. As a major pharmaceutical distributor and healthcare solutions provider, Amerisourcebergen Drug Corp plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.